Skip to main content

Table 3 Hyponatraemia associated symptoms

From: Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study

 

All patients

(n = 147)

Group A

(n = 20)

Group B

(n = 41)

Group C

(n = 86)

P a

Patients with symptoms (%)

n = 147

83 (56.5)

19 (95.0)

23 (56.1)

41 (47.7)

<.001

Severe neurologic symptoms (%)

n = 147

13 (8.8)

7 (35.0)

2 (4.9)

4 (4.7)

.001

 - Seizure (%)

n = 147

9 (6.1)

4 (20.0)

1 (2.4)

4 (4.7)

.03

 - Coma (%)

n = 147

4 (15.0)

3 (15.0)

1 (2.4)

0 (0)

.003

Confusion (%)

n = 147

42 (28.6)

10 (50.0)

11 (26.8)

21 (24.4)

.08

Nausea/vomiting (%)

n = 147

17 (11.6)

3 (15.0)

6 (14.6)

8 (9.3)

.50

Gait disturbance/Fall (%)

n = 147

20 (13.6)

4 (20.0)

7 (17.1)

9 (10.5)

.38

Other symptoms (%)

n = 147

7 (4.8)

2 (10.0)

2 (4.9)

3 (3.5)

.32

  1. Group A: plasma sodium <110 mmol/l; group B: plasma sodium 110–115 mmol/l; group C: plasma sodium 116–120 mmol/l. abetween group A, B and C